COMPARING COSTS OF ANTI-TNF THERAPY BY ADMINSTRATION ROUTE FOR PATIENTS WITH ANKYLOSING SPONDYLITIS AND RHEUMATOID ARTHRITIS IN FRANCE IN 2012: A BUDGET IMPACT MODEL

被引：0
|
作者：
Chevreul, K. [1 ]
Bourguignon, S. [2 ]
Granados, D. [3 ]
机构：
[1] Unite Rech Clin Econ Sante Ile de France, Paris, France
[2] Strateg Sante, Bondoufle, France
[3] Abbott Labs, Rungis, France
来源：
VALUE IN HEALTH | 2012年 / 15卷 / 07期
关键词：
D O I：
10.1016/j.jval.2012.08.1365
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A440 / A441
页数：2
相关论文
共 50 条
  • [1] PERSISTENCY WITH SUBCUTANEOUS ANTI-TNF THERAPY FOR TREATMENT OF RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS, AND ANKYLOSING SPONDYLITIS PATIENTS
    Tandon, N.
    Haas, S.
    Waters, H.
    Olson, W.
    Bolge, S.
    Gunnarsson, C.
    VALUE IN HEALTH, 2012, 15 (04) : A41 - A41
  • [2] Anti-TNF alpha in the treatment of rheumatoid arthritis and ankylosing spondylitis
    Lanfant-Weybel, Karine
    Lequerre, Thierry
    Vittecoq, Olivier
    PRESSE MEDICALE, 2009, 38 (05): : 774 - 787
  • [3] EFFECTS OF ANTI-TNF THERAPY ON MARKERS OF BONE HOMEOSTASIS IN RHEUMATOID ARTHRITIS AND ANKYLOSING SPONDYLITIS
    Horvth, A.
    Pusztai, A.
    Gulyas, K.
    Vancsa, A.
    Vegh, E.
    Bodnar, N.
    Csomor, P.
    Petho, Z.
    Juhsaz, B.
    Szentpetery, A.
    Szamosi, S.
    Bhattoa, H.
    Szanto, S.
    Szucs, G.
    Nagy, Z.
    Szekanecz, Z.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : A37 - A37
  • [4] EFFECTS OF ANTI-TNF THERAPY ON MARKERS OF BONE HOMEOSTASIS IN RHEUMATOID ARTHRITIS AND ANKYLOSING SPONDYLITIS
    Horvath, A.
    Pusztai, A.
    Gulyas, K.
    Vancsa, A.
    Vegh, E.
    Bodnar, N.
    Csomor, P.
    Pethoe, Z.
    Juhasz, B.
    Szentpetery, A.
    Szamosi, S.
    Bhattoa, H. P.
    Szanto, S.
    Szuecs, G.
    Nagy, Z.
    Szekanecz, Z.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 175 - 175
  • [5] Impact of medical practices on the costs of management of rheumatoid arthritis by anti-TNFα biological therapy in France
    Fautrel, B
    Woronoff-Lemsi, MC
    Ethgen, M
    Fein, E
    Monnet, P
    Sibilia, J
    Wendling, D
    JOINT BONE SPINE, 2005, 72 (06) : 550 - 556
  • [6] Medication Persistence among Rheumatoid Arthritis and Ankylosing Spondylitis Patients under DMARD and Anti-TNF Therapy in Brazil
    Machado, Marina
    Moura, Cristiano
    Bernatsky, Sasha
    Rahme, Elham
    Acurcio, Francisco
    JOURNAL OF RHEUMATOLOGY, 2015, 42 (07) : 1294 - 1295
  • [7] IMPACT OF ANTI-TNF THERAPY ON BASDAI AND EMPLOYMENT IN ANKYLOSING SPONDYLITIS
    Holmes, A.
    Parker, S.
    Smith, H.
    Briggs, N.
    Arthanari, S.
    Nisar, M.
    RHEUMATOLOGY, 2012, 51 : 62 - 63
  • [8] THE IMPACT OF ANTI-TNF-THERAPY ON ENDOTHELIAL FUNCTION IN PATIENTS WITH RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS OR ANKYLOSING SPONDYLITIS
    Heinz, K.
    Oelzner, P.
    Eidner, T.
    Goetze, K.
    Saemann, A.
    Wolf, G.
    Neumann, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 582 - 582
  • [9] ANALYSIS OF THE BUDGET IMPACT OF SECUKINUMAB USE VERSUS ANTI-TNF AGENTS IN ANKYLOSING SPONDYLITIS PATIENTS
    Romero Prada, M. E.
    Roa, Cardenas N. C.
    Serrano, G. Y.
    Huerfano, L. M.
    VALUE IN HEALTH, 2017, 20 (09) : A937 - A937
  • [10] Physical therapy in anti-TNF treated patients with ankylosing spondylitis
    Dubey, S. G.
    Leeder, J.
    Gaffney, K.
    RHEUMATOLOGY, 2008, 47 (07) : 1100 - 1101
12345